Interferon-alpha induced changes in CEA expression in patients with CEA- producing tumours

European Journal of Nuclear Medicine

Volumn 27, Issue 2, 2000, Pages 209-213

  Verhaar Langereis, Marlies J ^a   Bongers, Vivian ^a   de Klerk, John M H ^a   van Dijk, Aalt ^a   Blijham, Geert H ^a   Zonnenberg, Bernard A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

99mTc CEA Scan; Interferon Tumour targeting Carcinoembryonic antigen

Indexed keywords

ALPHA INTERFERON; ARCITUMOMAB TC 99M; CARCINOEMBRYONIC ANTIGEN; RHENIUM 186;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER SCINTISCANNING; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG HALF LIFE; DRUG TARGETING; DRUG UPTAKE; FEMALE; HUMAN; IMMUNOSCINTIGRAPHY; MALE; RADIOIMMUNOTHERAPY;

ADULT; AGED; CARCINOEMBRYONIC ANTIGEN; FEMALE; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; NEOPLASMS; RADIOIMMUNODETECTION; TECHNETIUM;

EID: 0033952478     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050029     Document Type: Article

References (10)

1. 1. Kaminski MS, Zasandry KR, Francis IR, et al. Radioimmunotherapy of B-cell lymphoma with (I-131) anti-B1 (anti-CD20) antibody. N Eng J Med 1993; 329: 459-465.
2. 2. J Nucl Med 1996; 73: 1504-1510.
3. 3. Greiner JW, Guadagni F, Goldstein D, et al. Intraperitoneal administration of interferon-gamma to carcinoma patients enhances expression of tumour-associated glycoprotein-72 and carcinoembryonic antigen on malignant ascites cells. J Clin Oncol 1992; 10:735-746.
4. 4. Rosenblum MG, Lamki LM, Murray JL, et al. Interferon induced changes in pharmacokinetics and tumour uptake of indium-111 labeled antimelanoma antibody 96.5 in melanoma patients. J Natl Cancer Inst 1988; 80: 160-165.
5. 5. Meredith RF, Khazaeli MB, Plott WE, et al. Phase II study of dual 131-1 labeled monlonal antibody therapy with interferon in patients with metastatic colon cancer. Clin Cancer Res 1996; 2: 1811-1818.
6. 6. Griffiths GL, Goldenberg DM, Diril H, et al. Technetium-99m, rhenium-186, and rhenium-188 direct-labeled antibodies. Cancer 1994; 73: 761-768.
7. 7. Verhaar M.J, Damen CA, Zonnenberg BA, Blijham GH. In vitro upregulation of carcinoembryonic antigen expression by combinations of cytokines. Cancer Lett 1999; 139: 76-73.
8. 8. Dansky Ullmann C, Salgaller M, Adams S, et al. Synergistic effects of I1-6 and IFN-gamma on carcinoembryonic antigen (CEA) and HLA expression by human colorectal carcinoma cells; role for endogenous IFN-beta. Cytokine 1995; 7: 118-129.
9. 9. Goldenberg DM, Juweid M, Dunn RM, et al. Cancer imaging with radiolabelled antibodies: new advances with technetiumlabelled monoclonal antibody Fab' fragments, especially CEA-Scan, and prospects for therapy. J Nucl Med Technol 1997; 25: 18-23.
10. 10. Behr TM, Sharkey RM, Juweid ME, et al. Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodies. J Nucl Med 1997; 38: 409-418.